Analyst Ratings for Mednax Inc. (MD)

Updated: 2017-07-26

Shares of Mednax Inc. (NYSE:MD) have received a consensus rating of Hold from Wall Street analysts. A consensus rating of Hold was previously issued for MD last month.

Of the 14 analysts covering the stock, 2 gave it a buy rating, 0 gave an overweight rating, 11 issued a hold rating, 1 gave an underweight rating, and 0 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 0. Meanwhile, the number of analysts pessimistic about the company has increased by 0.

Many analysts weighed in on price targets for MD. The maximum price target given was 68, implying potential capital gains of 20.06 percent. The most pessimistic price target was 53, which equates to a potential downside of -6.43 percent. Some investors take price targets and stock ratings with a grain of salt, knowing that some analysts can have indirect business with the stocks they cover.

Analysts have revised their earnings estimates upwards for this quarter, by about 0 percent on average, compared to last month. The average change in earnings estimates over the last 90 days is -16.86 percent. Over the past 30 days, FY earnings estimates have also changed downwards by -0.72 percent. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes -13.41 percent.

Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. 0 analysts have revised their quarterly estimates upwards in the past 30 days, while 0 analysts revised their estimates downwards. During this time, 0 analysts made positive revisions in their estimates for this fiscal year's earnings, while 2 analysts made negative revisions to their fiscal year's estimates.

The growth rate of MD's earnings is estimated by analysts to be -1.81 percent. The PEG ratio of a stock is another value frequently studied by investors. A lower PEG ratio is favorable, because people typically see that as an indicator of higher growth relative to stock price. Many investors consider PEG ratios between 0 and 1 as preferrable, even though it may be more relevant to compare the ratio to that of a firm's competitors. MD has a PEG ratio of -9.31.

In the trailing 52-weeks, MD hit 75.83 at the highest peak, while it's lowest trading point was 53.80. Currently the stock is 5.28 percent higher than its low, and 25.31 percent below the high. MD has a price/earnings ratio of 16.86. Investors typically compare the P/E ratio to a company's peers in the industry. The MD value stock report compares MD to some of its peers using value stock charts. The stock has a market capitalization of $5.33 billion. MD is estimated to release their earnings results for the quarter on 0000-00-00, days from today.